688488: Jiangsu Aidea Pharmaceutical Co.Ltd(688488) notice on convening the second extraordinary general meeting of shareholders in 2022

Securities code: 688488 securities abbreviation: Jiangsu Aidea Pharmaceutical Co.Ltd(688488) Announcement No.: 2022-011 Jiangsu Aidea Pharmaceutical Co.Ltd(688488)

Notice on convening the second extraordinary general meeting of shareholders in 2022

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and bear legal liabilities for the authenticity, accuracy and completeness of the contents according to law.

Important content tips:

Date of shareholders’ meeting: February 16, 2022

The online voting system adopted by the general meeting of shareholders: the online voting system of the general meeting of shareholders of Shanghai Stock Exchange

1、 Basic information of the meeting (I) type and session of the general meeting of shareholders

The second extraordinary general meeting of shareholders in 2022 (II) convener of the general meeting of shareholders: Board of directors (III) voting method: the voting method adopted at the general meeting of shareholders is a combination of on-site voting and online voting (IV) date, time and place of the on-site meeting

Date and time: 14:30, February 16, 2022

Venue: conference room (V) on the first floor, No. 69, xinganquan West Road, Hanjiang District, Yangzhou city. Online voting system, start and end date and voting time.

Online voting system: online voting system for shareholders’ meeting of Shanghai Stock Exchange

Starting and ending time of online voting: from February 16, 2022

To February 16, 2022

The online voting system of Shanghai Stock Exchange is adopted. The voting time through the trading system voting platform is the trading time period on the day of the general meeting of shareholders, i.e. 9:15-9:25, 9:30-11:30, 13:00-15:00; The voting time through the Internet voting platform is 9:15-15:00 on the day of the general meeting of shareholders. (VI) voting procedures for margin trading, refinancing, agreed repurchase business accounts and investors of Shanghai Stock connect

The voting of investors involved in margin trading, refinancing business, agreed repurchase business and Shanghai Stock connect shall be carried out in accordance with the implementation rules for online voting at the general meeting of shareholders of listed companies of Shanghai Stock Exchange and other relevant provisions. (VII) involving public solicitation of shareholders’ voting rights

According to the relevant provisions of the measures for the administration of equity incentive of listed companies of the CSRC, the shareholders’ meeting involves the public solicitation of shareholders’ voting rights, and the independent director Mr. Zhang Changqing, as the soliciter, solicits the voting rights of all shareholders of the company on the proposals related to equity incentive considered at the shareholders’ meeting. For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement on public solicitation of entrusted voting rights by independent directors (Announcement No.: 2022-012). 2、 Matters considered at the meeting

Types of shareholders deliberating proposals and voting at the general meeting of shareholders

Voting shareholder type serial number proposal name A-share shareholder

Non cumulative voting motion

About the company’s restricted stock incentive plan in 2022 (Draft) >√

1. Proposal for and its summary

Assessment management on the implementation of the company’s restricted stock incentive plan in 2022 √

2. Proposal on “management measures”

Proposal to the general meeting of shareholders of the company to authorize the board of directors to handle equity incentive

3 √

Proposal on Relevant Issues

1. Explain the time and media of disclosure of each proposal

(1) The above proposals 1-3 have been deliberated and adopted at the 21st Meeting of the first board of directors of the company, and proposals 1-2 have been deliberated and adopted at the 17th meeting of the first board of supervisors of the company.

(2) The specific contents of the above proposal are detailed in the website of Shanghai Stock Exchange on January 20, 2022( http://www.sse.com.cn. )And relevant announcements disclosed in China Securities Journal, Shanghai Securities News, securities times and Securities Daily.

(3) Before the second extraordinary general meeting of shareholders in 2022, the company will be on the website of Shanghai Stock Exchange( http://www.sse.com.cn. )Publish the Jiangsu Aidea Pharmaceutical Co.Ltd(688488) materials of the second extraordinary general meeting of shareholders in 2022. 2. Special resolution proposal: proposal 1, 2, 33. Proposal on separate vote counting for small and medium-sized investors: proposal 1, 2, 34. Proposal involving avoidance of voting by related shareholders: proposal 1, 2, 3

Names of related shareholders who should avoid voting: Guangzhou Weimei Investment Co., Ltd., Weimei investment (Hong Kong) Co., Ltd., Aegle tech Limited, Fu Hexiang, Wu Dongsheng, Shanghai LeYang Kairui enterprise management partnership (limited partnership), avidian tech Limited, Wu Rongrong and Wang Jun. 5. Proposals involving the voting of preferred shareholders: No. III. voting precautions for the general meeting of shareholders (I) if the shareholders of the company exercise their voting rights through the online voting system of the general meeting of shareholders of Shanghai Stock Exchange, they can log in to the voting platform of the trading system (through the trading terminal of the securities company designated for trading) to vote, You can also log in to the Internet voting platform (website: vote. Sseinfo. Com.) Vote. For the first time to log in to the Internet voting platform to vote, investors need to complete shareholder identity authentication. Please refer to the instructions on the Internet voting platform website for specific operations. (II) if the same voting right is voted repeatedly through the on-site, online voting platform of the exchange or other means, the first voting result shall prevail. (III) shareholders can submit all proposals only after voting. 4、 Participants of the meeting (I) at the closing of the afternoon of the equity registration day, the shareholders of the company registered in China depository and Clearing Co., Ltd. Shanghai branch have the right to attend the general meeting of shareholders (see the table below for details), and can entrust agents to attend the meeting and vote in writing. The agent need not be a shareholder of the company.

Stock class stock code stock abbreviation equity registration date

A shares 688488 Jiangsu Aidea Pharmaceutical Co.Ltd(688488) 2022 / 2 / 10

(II) directors, supervisors and senior managers of the company. (III) lawyers employed by the company. (IV) other personnel v. meeting registration method

1. The legal representative or the entrusted agent of the legal person shareholder shall attend the meeting. If the legal representative attends the meeting, he / she shall register with the company with a copy of the business license (stamped with the company’s official seal), his / her ID card and the account card of the legal person shareholder; If the legal representative entrusts an agent to attend the meeting, the agent shall register with the company with a copy of the business license of the legal person (stamped with the official seal), the ID card of the agent, the power of attorney issued by the legal representative according to law (stamped with the official seal) and the account card of the legal person shareholder.

2. If a natural person shareholder attends the meeting in person, he / she shall register with the company with his / her ID card and shareholder account card; If an agent is entrusted to attend the meeting, the agent shall register with the company with his ID card, power of attorney and shareholder account card.

3. Non local shareholders can register by letter or fax, which must be delivered before 17:00 p.m. on February 15, 2022. The letter or fax shall be subject to the time of arrival at the company. The letter shall indicate the shareholder’s contact person, contact information and the words “general meeting of shareholders”. The letter or fax registration shall be attached with the copies of the supporting materials listed in paragraphs 1 and 2 above, and the original shall be brought when attending the meeting. 6、 Other matters

(I) if a shareholder or his agent is unable to attend the meeting or vote due to failing to carry valid certificates as required or failing to go through the registration procedures in time, all consequences shall be borne by the shareholder or his agent. (II) affected by covid-19 pneumonia, the company encourages all shareholders to give priority to participating in the general meeting of shareholders by online voting through the online voting system of Shanghai Stock Exchange. If you really need to attend the meeting on site, please ensure that your temperature is normal and there are no symptoms such as respiratory discomfort. You must wear masks and other protective equipment on the day of the meeting and do a good job of personal protection; On the day of the meeting, the company will measure and register the temperature of participants according to the requirements of epidemic prevention and control. Only those with normal temperature can attend the meeting. Please cooperate. The shareholders or agents attending the meeting shall bear their own transportation and accommodation expenses.

(III) shareholders attending the meeting shall arrive at the meeting site half an hour in advance to sign in.

(IV) meeting contact information

Contact address: No. 69, xinganquan West Road, Hanjiang District, Yangzhou

Tel: + 86-514-82090238

Contact Fax: + 86-514-87736366 email: [email protected]. Contact: Wang Guangrong hereby announces.

Jiangsu Aidea Pharmaceutical Co.Ltd(688488) board of directors January 20, 2022 Annex 1: power of attorney

Power of attorney

Jiangsu Aidea Pharmaceutical Co.Ltd(688488) :

I hereby entrust Mr. (Ms.) to attend the second extraordinary general meeting of shareholders of your company in 2022 held on February 16, 2022 on behalf of my unit (or myself) and exercise voting rights on behalf of me. Number of ordinary shares held by the trustor: number of preferred shares held by the trustor: account number of the trustor’s shareholder:

No. name of non cumulative voting proposal agree against abstain

About the company’s incentive plan for restricted shares in 2022

1. Proposal for planning (Draft) > and its summary

About the company’s incentive plan for restricted shares in 2022

2. Proposal on implementing assessment management measures

Notice on submitting to the general meeting of shareholders of the company to authorize the board of directors to do

3. Proposal on matters related to equity incentive

Signature (seal) of the trustor: signature of the trustee:

The ID number of the client: the ID number of the trustee:

Entrusted date: mm / DD / yy

remarks:

The trustor shall select one of the “agree”, “oppose” or “abstain” intentions in the power of attorney and tick “√”. If the trustor does not give specific instructions in the power of attorney, the trustee has the right to vote according to its own wishes.

- Advertisment -